Skip to main content
Clinical Trials/NCT02703948
NCT02703948CompletedNot Applicable

Injection Technique Assessment of Restylane Silk With Lidocaine for Lip Augmentation

Galderma R&D4 sites in 1 country60 target enrollmentStarted: March 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
60
Locations
4
Primary Endpoint
Number of Participants With Adverse Events With the Use of Restylane Silk With Lidocaine

Study Overview

Brief Summary

This is a multi-center, open-label, single-arm study to assess the safety of an injection technique with Restylane Silk in lip augmentation and correction of perioral rhytids .

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
22 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Subjects willing to comply with the requirements of the study and providing written informed consent including release of copyright of photography images.
  • •Males or females, 22 years of age or older
  • •Subjects seeking augmentation therapy for the lips.

Exclusion Criteria

  • •History of allergy or hypersensitivity to injectable HA gel or to gram positive bacterial proteins.
  • •History of allergy or hypersensitivity to lidocaine, other amide type anesthetics, or topical anesthetics or nerve blocking agents
  • •Previous surgery to the upper or lower lip, lip piercing or tattoo, or history of facial trauma.

Arms & Interventions

Restylane Silk with Lidocaine

Other

Intervention: Restylane Silk with Lidocaine (Device)

Outcomes

Primary Outcomes

Number of Participants With Adverse Events With the Use of Restylane Silk With Lidocaine

Time Frame: 12 weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (4)

Loading locations...

Similar Trials